WallStreetZenWallStreetZen

NASDAQ: LPCN
Lipocine Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their LPCN stock forecasts and price targets.

Forecast return on equity

Is LPCN forecast to generate an efficient return?
Company
24.93%
Industry
29.69%
Market
89.37%
LPCN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is LPCN forecast to generate an efficient return on assets?
Company
23.42%
Industry
11.82%
LPCN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

LPCN revenue growth forecast

How is LPCN forecast to perform vs Biotechnology companies and vs the US market?
Company
495.79%
Industry
64.21%
Market
8.83%
LPCN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
LPCN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

LPCN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
LPCN$4.30N/AN/A
AXLA$0.31$2.00+551.47%Hold
MRKR$2.51N/AN/A
EQ$0.66$6.50+883.36%Strong Buy
NRSN$1.86N/AN/A

Lipocine Stock Forecast FAQ

What is LPCN's forecast return on equity (ROE) for 2023-2025?

(NASDAQ: LPCN) forecast ROE is 24.93%, which is considered strong.

If you're new to stock investing, here's how to buy Lipocine stock.

What is LPCN's forecast return on assets (ROA) for 2023-2025?

(NASDAQ: LPCN) forecast ROA is 23.42%, which is higher than the forecast US Biotechnology industry average of 11.82%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.